Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109048) titled 'Safety and Effectiveness of Finerenone in Fatty Liver-Related Cirrhosis with Ascites to Prevent Kidney Disease' on April 22.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Centralized Blinding and masking:Open Label
Primary Sponsor: Institute of Liver and Biliary Sciences
Condition:
Health Condition 1: N181- Chronic kidney disease, stage 1
Health Condition 2: K760- Fatty (change of) liver, not elsewhere classified
Intervention:
Intervention1: Fi...